Schein Contract Manufactured Penicillin G To Reach Market In 2nd Quarter
Executive Summary
Schein plans to re-introduce a contract manufactured penicillin G potassium product during the second quarter of 2000.
You may also be interested in...
Schein Will Lay-Off 120 Employees, Consider Sale Of Company
Schein Pharmaceuticals plans to lay off about 120 employees to reduce its operating costs, the company said.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials